INDV 6-K
Indivior Pharmaceuticals, Inc. (INDV)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
For the month of November 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F ☒ Form 40-F ☐
EXHIBIT INDEX
| Exhibit<br>No. | Description<br>of Exhibit |
|---|---|
| 99.1 | Announcement sent<br>to the London Stock Exchange on November 11, 2024, titled<br>“Holding(s) in Company”. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Indivior PLC | |
|---|---|
| Date: November 11, 2024 | /s/<br>Kathryn Hudson |
| Name:<br>Kathryn Hudson | |
| Title:<br>Company Secretary |
a7578l-announcement
Exhibit 99.1
TR-1: Standard form for notification of major holdings
- Issuer Details
ISIN
| GB00BN4HT335 |
|---|
Issuer Name
| INDIVIOR PLC |
|---|
UK or Non-UK Issuer
| UK |
|---|
- Reason for Notification
| An acquisition or disposal of voting rights |
|---|
- Details of person subject to the notification obligation
Name
| Deerfield Management Company, L.P. (Series C) |
|---|
City of registered office (if applicable)
Country of registered office (if applicable)
| US |
|---|
- Details of the shareholder
Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above
| Deerfield Partners, L.P. |
|---|
City of registered office (if applicable)
Country of registered office (if applicable)
| U.S. |
|---|
- Date on which the threshold was crossed or reached
| 08-Nov-2024 |
|---|
- Date on which Issuer notified
| 11-Nov-2024 |
|---|
- Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 +<br>8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
|---|---|---|---|---|
| Resulting<br>situation on the date on which threshold was crossed or<br>reached | 5.165000 | 0.000000 | 5.165000 | 6567399 |
| Position<br>of previous notification (if applicable) |
- Notified details of the resulting situation on the date on which the threshold was crossed or reached
8A. Voting rights attached to shares
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
|---|---|---|---|---|
| GB00BN4HT335 | 6567399 | 0 | 5.165000 | 0.000000 |
| Sub<br>Total 8.A | 6567399 | 5.165000% |
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is<br>exercised/converted | % of voting rights |
|---|---|---|---|---|
| Sub<br>Total 8.B1 |
8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
|---|---|---|---|---|---|
| Sub<br>Total 8.B2 |
- Information in relation to the person subject to the notification obligation
| 2. Full chain of controlled undertakings through which the voting<br>rights and/or the financial instruments are effectively held<br>starting with the ultimate controlling natural person or legal<br>entities (please add additional rows as necessary) | ||||
|---|---|---|---|---|
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable<br>threshold | % of voting rights through financial instruments if it equals or is<br>higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable<br>threshold |
| --- | --- | --- | --- | --- |
| James<br>E. Flynn (Chain 1) | Flynn<br>Management LLC | 5.165000 | 0.000000 | 5.165000% |
| James<br>E. Flynn (Chain 1) | Deerfield<br>Management Company, L.P. | |||
| James<br>E. Flynn (Chain 1) | Deerfield Partners,<br>L.P | 5.165000 | 0.000000 | 5.165000% |
| James<br>E. Flynn (Chain 2) | J.E.<br>Flynn Capital, LLC. | |||
| James<br>E. Flynn (Chain 2) | Deerfield Mgmt,<br>L.P. | |||
| James<br>E. Flynn (Chain 2) | Deerfield Partners,<br>L.P. | 5.165000 | 0.000000 | 5.165000% |
- In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
- Additional Information
- Date of Completion
| 11-Nov-2024 |
|---|
- Place Of Completion
| New York, NY |
|---|